SILVER SPRING, Md.—The U.S. Food and Drug Administration (FDA) has issued new labeling recommendations for hydrogen peroxide-based contact lens care products (HPCPs), the American Optometric Association reported. These recommendations aim to reduce the risk of serious eye injuries associated with the products. The guidance, which was issued on July 26, 2023, applies to HPCPs submitted in premarket notification (510(k)) and will help manufacturers develop labeling with information about specific risks and directions for use of the HPCPs in conjunction with a user’s prescribed lenses, the AOA said.

The FDA noted that the labeling recommendations are intended to promote the safe and effective use of HCPS, while ensuring that customers receive and understand information regarding the benefits and risks associated with use, according to the AOA.

The full guidance document is available from the FDA online here.